Author page: Femtech Insider

Elvie Launches Elvie Stride, a New Smart Breast Pump Covered by Insurance in the U.S.

U.K.-based femtech pioneer Elvie has announced the launch of Elvie Stride, a new smart, ultra-quiet, hands-free breast pump and the first of Elvie’s products to be broadly covered by insurance in the U.S. Elvie Stride joins the company’s collection of breastfeeding innovations, including the silent wearable breast pump, Elvie Pump, as well as the smart device for pelvic floor muscle care, Elvie Trainer. Elvie developed…

Breast Cancer NPO The Chrysalis Initiative Launches Mobile App BC Navi to Fight Biased Healthcare

The National Cancer Institute’s ​​Surveillance, Epidemiology, and End Results (SEER) Program has reported that approximately 12.9% of women will get diagnosed with cancer in their lifetime. Although Black women get breast cancer at a slightly lower incidence rate (3%) than white women, Black women are 42% more likely to face mortality. This Fall, The Chrysalis Initiative (TCI) will launch BC Navi, a…

What’s New in Femtech This Week? (Sep 16, 2021)

Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page. Along with 10 partners, many from the femtech ecosystem, virtual abortion care startup Hey Jane published a full-page letter in the New York Times, condemning the abortion bans…

Toronto-based DTC Fertility Startup Bird & Be Launches with $1.8M in Funding

Toronto-based DTC Fertility startup Bird & Be has announced a $1.8M financing round led by BAM Ventures, an early-stage consumer fund founded by Brian Lee, co-founder and former CEO of LegalZoom and the Honest Company. Other investors participating in the round are Elliot Cohen, Co-founder of PillPack, Slow Ventures, JJ Wilson , Judy Brooks, HaloHealth, Backbone Angels, and Fitt Ventures. Bird & Be offers direct-to-consumer, personalized at-home kits designed…

Launched: ‘Love, MeMeMe’, a New Gender-Neutral Self Care Brand and CBD-based Product Line

Love, MeMeMe is a new self care brand on a mission to reclaim the concept of ‘Me Time’. The brand has curated a line of gender-neutral self care products fusing CBD and other active ingredients. The message? Self care starts with self love. To launch the brand, Love, MeMeMe has enlisted British singer songwriter and rising star, Mae Muller to debut the…

Cleo Introduces Its New Clinical Advisory Board to Further Health Outcomes and Support for Working Families

Cleo, the support benefit for working families has announced a new Clinical Advisory Board consisting of five industry leading health professionals. Collectively, the board brings a progressive and holistic approach to areas including neonatal development, pediatric care, better Medicaid support for marginalized communities, and improved Black maternal health outcomes. Joining Cleo’s Co-founder and Chief Medical Officer, Chitra Akileswaran, MD, on Cleo’s Clinical Advisory Board are: Dr. Monica…

Sonder Health Adds BehaVR’s VR-based Maternal Mental Health Solution to Its Telehealth Offering

Sonder Health and BehaVR have announced a new partnership to offer NurtureVR, a VR-based digital therapeutic to help expectant mothers with stress, anxiety and fear as an additional support tool to users of Sonder Health’s telelactation and telenutrition clinical services. When combined with BehaVR’s NurtureVR program, the Sonder Health telemedicine platform provides moms-to-be and new moms with 24/7/365 support. BehaVR’s partnership with Sonder Health provides…

Field Trip Pursues Postpartum Depression and Treatment Resistant Depression as Lead Indications for FT-104, Its Novel Psychedelic Compound

Field Trip, a leader in the development and delivery of psychedelic therapies, has announced the lead indications for FT-104, its novel psychedelic compound in development, will be Treatment Resistant Depression (TRD) and Postpartum Depression (PPD). Through Field Trip Discovery, its drug development division, Field Trip is developing next-generation psychedelic molecules. Its first molecule in development, FT-104, a prodrug, is a synthetic serotonin-2A…